University of California San Diego Health

Sewage-Handling Robots Help Predict COVID-19 Outbreaks in San Diego

Automated process helps test city sewage for SARS-CoV-2, allowing researchers to forecast the region’s caseload one to two weeks ahead of clinical diagnostic reports

Newswise — In earlier days of the COVID-19 pandemic, before diagnostic testing was widely available, it was difficult for public health officials to keep track of the infection’s spread, or predict where outbreaks were likely to occur. Attempts to get ahead of the virus are still complicated by the fact that people can be infected and spread the virus even without experiencing any symptoms themselves.

When studies emerged showing that a person testing positive for COVID-19 — whether or not they were symptomatic — shed the virus in their stool, “the sewer seemed like the ‘happening’ place to look for it,” said Smruthi Karthikeyan, PhD, an environmental engineer and postdoctoral researcher at University of California San Diego School of Medicine.

From July to November 2020, Karthikeyan and team, led by Rob Knight, PhD, professor and director of the Center for Microbiome Innovation at UC San Diego, sampled sewage water to see if they could detect SARS-CoV-2, the virus that causes COVID-19. They could. But concentrating the wastewater proved to be a bottleneck — it’s a slow and laborious multi-step process.

Now, in a paper published March 2, 2021 in mSystems, the researchers describe how they have automated wastewater concentration with the help of liquid-handling robots. They demonstrated their system’s robustness by comparing it to existing methods and showing that they can predict COVID-19 cases in San Diego by a week with excellent accuracy, and three weeks with fair accuracy, just using city sewage.

San Diego County has only one primary wastewater treatment plant, located on the coast in the city’s Point Loma neighborhood. All excrement flushed away by San Diego’s approximately 2.3 million residents, including those on the UC San Diego campus, ends up there.

Seven days a week, Karthikeyan or a colleague drove down to the treatment plant to pick up wastewater samples that had been collected and stored for them by on-site lab technicians. They brought the samples to Knight’s lab on the UC San Diego School of Medicine campus in La Jolla.

“Unfortunately, we can’t just directly test wastewater samples the way we would samples from patient nasal swabs,” Karthikeyan said. “That’s because the samples we get are highly diluted — just think of the number of people contributing to the waste stream, plus all the junk that gets flushed and makes it to the sewer system.”

Back in the lab, the researchers process the sewage using their robotic platform. The system extracts RNA — the genetic material that makes up the genomes of viruses like SARS-CoV-2 — from the samples, and runs polymerase chain reaction (PCR) to search for the virus’ signature genes. The automated, high-throughput system can process 24 samples every 40 minutes. Later the same day, Karthikeyan adds the data to a digital dashboard that tracks new positive cases.

According to Knight, the technique is faster, cheaper and more sensitive than other approaches to wastewater surveillance. The team is able to identify a single COVID-19 case in a building of approximately 500 people.

Wastewater monitoring key to UC San Diego’s Return to Learn program

The researchers and students in Knight’s lab are no strangers to dealing with stool samples. The team has long been known for their studies of the gut microbiome — the unique communities of microbes that live in our gastrointestinal tracts. People all over the world participate in their research program, The Microsetta Initiative (aptly abbreviated “TMI”), by mailing their fecal swabs to Knight’s UC San Diego lab. The crowdsourced project has allowed the team to study the many factors that might influence the makeup of a person’s gut microbiome, and the many ways it influences our health.

In the spring of 2020, Knight’s team quickly pivoted their focus to look for one particular microbe: SARS-CoV-2. Soon the team formed an integral part of UC San Diego’s Return to Learn program, an evidence-based approach that has allowed the university to continue to offer on-campus housing and in-person classes and research opportunities. With approximately 10,000 students on campus, the many components of the program have kept COVID-19 case rates much lower than the surrounding community and most college campuses, maintaining a positivity rate of less than 1 percent.

Return to Learn relies on three pillars: risk mitigation, viral detection and intervention. Knight’s team and their collaborators play a big role in viral detection on campus. They help screen for the asymptomatic presence of SARS-CoV-2 in students and staff (often self-collected using test kits available from vending machines), on surfaces and in wastewater.

The team continues to collect samples daily from more than 100 wastewater samplers on the UC San Diego campus, which cover more than 300 buildings. Approximately one month after the campus detection system came online in summer 2020, a positive case was detected in the Revelle College area one Friday afternoon. The campus community was notified within 14 hours and targeted messages were sent to people associated with the affected buildings, recommending they be tested for the virus as soon as possible. More than 650 people were tested for COVID-19 that weekend.

As a result, two asymptomatic individuals were identified as being positive for COVID-19. After the campus promptly notified them, they self-isolated before an outbreak could occur. Now, wastewater screening results are available on a public dashboard and positive samples are being sequenced to track the emergence of new SARS-CoV-2 variants. The Return to Learn program, including wastewater testing, has become a model for other universities, K-12 school districts and regions.

“As the barrier to entry and operate continues to drop, we hope wastewater-based epidemiology will become more widely adopted,” Knight said. “Rapid, large-scale infectious disease early alert systems could be particularly useful for community surveillance in vulnerable populations and communities with less access to diagnostic testing and fewer opportunities to distance and isolate — during this pandemic, and the next.”

Co-authors of the study also include Nancy Ronquillo, Pedro Belda-Ferre, Destiny Alvarado, Tara Javidi and Christopher A. Longhurst, all at UC San Diego.

Funding for this research came, in part, from the UC San Diego Return to Learn Program.



Filters close

Showing results

1120 of 5833
access_time Embargo lifts in 2 days
Embargo will expire: 17-Jun-2021 11:00 AM EDT Released to reporters: 15-Jun-2021 1:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Jun-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 15-Jun-2021 1:05 PM EDT
Common cold combats COVID-19
Yale University

Exposure to the rhinovirus, the most frequent cause of the common cold, can protect against infection by the virus which causes COVID-19, Yale researchers have found.

Released: 15-Jun-2021 11:55 AM EDT
Researchers Develop More Reliable Rapid Tests for COVID-19
University of Maryland Medical Center

Researchers Develop More Reliable Rapid Tests for COVID-19 Public Release Date: 15-Jun-2021 00:00:00 US Eastern Time (24hr) Research News Release Contact Person: Deborah Kotz Contact Phone: 410-706-4255 Contact E-mail: Journal: Nature Protocols DOI: 10.1038/s41596-021-00546-w Funder: Grant Number(s): Meeting: Primary Keyword: Medicine/Health Keywords: Medicine/Health -> Diagnostics Medicine/Health -> Infectious/Emerging Diseases Subtitle: Tests Use Innovative Techniques That Improve Accuracy Rivaling Gold Standard PCR Test Summary: Researchers at the University of Maryland School of Medicine (UMSOM) have developed two rapid diagnostic tests for COVID-19 that are nearly as accurate as the gold-standard test currently used in laboratories. Unlike the gold standard test, which extracts RNA and uses it to amplify the DNA of the virus, these new tests can detect the presence of the virus in as little as five minutes using different methods.

Newswise: SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations
Released: 15-Jun-2021 11:40 AM EDT
SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations
UCLA Fielding School of Public Health

The number of COVID-19 variants is growing rapidly, so much that the scale and scope of mutation may pose a threat to the continuing successful use of the current vaccines and therapies. The findings, by an international team that includes University of California researchers, are being published in the June edition of the peer-reviewed journal EMBO Molecular Medicine. The pace of variation of the SARS-CoV-2 virus strains makes plain the threat that rapidly evolving new strains might give rise to escape variants, capable of limiting the efficacy of vaccines, therapies, and diagnostic tests.

Newswise:Video Embedded what-makes-us-sneeze
14-Jun-2021 5:20 PM EDT
What makes us sneeze?
Washington University in St. Louis

What exactly triggers a sneeze? A team led by researchers at Washington University School of Medicine in St. Louis has identified, in mice, specific cells and proteins that control the sneeze reflex. Better understanding of what causes us to sneeze — specifically how neurons behave in response to allergens and viruses — may point to treatments capable of slowing the spread of infectious respiratory diseases.

14-Jun-2021 11:40 AM EDT
Rapid exclusion of COVID-19 infection using AI, EKG technology
Mayo Clinic

Artificial intelligence (AI) may offer a way to accurately determine that a person is not infected with COVID-19. An international retrospective study finds that infection with SARS-CoV-2, the virus that causes COVID-19, creates subtle electrical changes in the heart. An AI-enhanced EKG can detect these changes and potentially be used as a rapid, reliable COVID-19 screening test to rule out COVID-19 infection.

Newswise: For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
Released: 14-Jun-2021 5:15 PM EDT
For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
Johns Hopkins Medicine

In a study published today in the Annals of Internal Medicine, Johns Hopkins Medicine researchers say they believe that, for the first time, there is evidence to show that three doses of vaccine increase antibody levels against SARS-CoV-2 — the virus that causes COVID 19 — more than the standard two-dose regimen for people who have received solid organ transplants.

Newswise: Broadway1_DTLA_sz.lowres-768x512.jpg
Released: 14-Jun-2021 4:05 PM EDT
What’s Next: The Ongoing Urban Exodus
University of California, Irvine

Many employees have come to prefer working from home after being forced to do so more than a year ago when the pandemic started. By some estimates, at least one-quarter of employees will still be working remotely multiple days a week at the end of 2021. For those whose jobs allow it, being untethered from the office might mean moving farther away from it – by a few miles or a few hundred.

Newswise: 267701_web.jpg
Released: 14-Jun-2021 2:50 PM EDT
New model accounts for the effect of behavior changes to predict COVID-19 cases
Brown University

By adding behavioral components to an infectious disease model, Brown University researchers have developed a new modeling approach that captures the peaks and valleys in new COVID-19 cases seen over the past 16 months.

Newswise: Masking, breakthrough infections and telehealth: Keck Medicine of USC experts on life after June 15
Released: 14-Jun-2021 2:05 PM EDT
Masking, breakthrough infections and telehealth: Keck Medicine of USC experts on life after June 15
Keck Medicine of USC

June 15 is a banner day in California. Most COVID-19 statewide restrictions will be eliminated, including physical distancing and in many situations, mask mandates. How will life change and how will it stay the same? Keck Medicine of USC experts weigh in on what to expect next in the golden state.

Showing results

1120 of 5833